Pilot study to test the efficacy and safety of activated recombinant factor VII (NovoSeven) in the treatment of refractory hemorrhagic cystitis following high-dose chemotherapy

被引:0
|
作者
A A Ashrani
D A Gabriel
J L Gajewski
D R Jacobs
D J Weisdorf
N S Key
机构
[1] University of Minnesota,Department of Medicine
[2] University of North Carolina,Department of Medicine
[3] MD Anderson Cancer Center,Department of Medicine
[4] University of Minnesota,Department of Epidemiology
[5] Mayo Clinic College of Medicine,Department of Internal Medicine, Division of Hematology
[6] Fox Chase – Temple University,Bone Marrow Transplant Program
[7] University of North Carolina,Department of Medicine, Division of Hematology
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:825 / 828
页数:3
相关论文
共 50 条
  • [1] Pilot study to test the efficacy and safety of activated recombinant factor VII (NovoSeven) in the treatment of refractory hemorrhagic cystitis following high-dose chemotherapy
    Ashrani, A. A.
    Gabriel, D. A.
    Gajewski, J. L.
    Jacobs, D. R., Jr.
    Weisdorf, D. J.
    Key, N. S.
    BONE MARROW TRANSPLANTATION, 2006, 38 (12) : 825 - 828
  • [2] Pilot study to test the efficacy and safety of recombinant factor VIIa (rFVIIa, NovoSeven™) in the treatment of refractory hemorrhagic cystitis following high dose chemotherapy
    Ashrani, AA
    Gabriel, DA
    Gajewski, JL
    Key, NS
    BLOOD, 2004, 104 (11) : 322A - 322A
  • [3] Safety and Efficacy of Recombinant Activated Factor VII (Novoseven) Administration in Pediatric ECMO Patients
    Kasniya, G.
    Salisbury, C.
    Heard, M. L.
    Maher, K.
    Deshpande, S. R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2016, 35 (04): : S421 - S422
  • [4] Comparison of efficacy and safety between aryogen recombinant activated factor VII (Aryoseven™) and Novoseven® in the main on-label (approved) indications of recombinant activated factor VII in Iran
    Eshghi, P.
    Kamyar, K.
    Abolghasemi, H.
    Karimi, M.
    Faranoush, M.
    Toogeh, G.
    Hoorfar, H.
    Dehdezi, B. K.
    Khoeiny, B.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 : 30 - 30
  • [5] Efficacy and safety of recombinant activated factor VII in the management of hemorrhagic shock due to trauma
    Hauser, C. J.
    Boffard, K. D.
    Dutton, R. P.
    GR, Bernard
    Croce, M. A.
    Holcomb, J. B.
    Leppaniemi, A. K.
    Parr, M. J. A.
    Vincent, J. L.
    Tortella, B. J.
    Dimsits, J.
    Bouillon, B.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 290 - 291
  • [6] Treatment of refractory bleeding after cardiac operations with low-dose recombinant activated factor VII (NovoSeven®):: a propensity score analysis
    Gelsomino, Sandro
    Lorusso, Roberto
    Romagnoli, Stefano
    Bevilacqua, Sergio
    De Cicco, Giuseppe
    Bille, Giuseppe
    Stefano, Pierluigi
    Gensini, Gian Franco
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2008, 33 (01) : 64 - 71
  • [7] EFFICACY AND SAFETY OF RECOMBINANT ACTIVATED FACTOR VII FOR THE TREATMENT OF PERIOPERATIVE BLEEDING
    Chang, Zhigang
    Liu, Dadong
    Liu, Yalin
    Ying, Jiaoqian
    CRITICAL CARE MEDICINE, 2019, 47
  • [8] Results of clinical study for single/high dose treatment by recombinant activated factor VII in Japan
    Shirahata, A.
    Shima, M.
    Oka, T.
    Amano, K.
    Hanabusa, H.
    Taki, M.
    Mimaya, J. .
    Matsushita, T.
    Takamatsu, J. .
    Higasa, S. .
    Kosaka, Y.
    Suga, K.
    Sakai, M.
    Kajiwara, M.
    Takata, N.
    Yoshioka, A.
    HAEMOPHILIA, 2008, 14 : 52 - 52
  • [9] Activated recombinant factor VII (rFVIIa/NovoSeven®) in the treatment of bleeding complications following hematopoietic stem cell transplantation (HSCT)
    Brenner, B
    Pihusch, M
    Bacigalupo, A
    Szer, J
    Prondzinski, MV
    Gaspar-Blaudschun, B
    Hyveled, L
    BLOOD, 2004, 104 (11) : 321A - 322A
  • [10] Efficacy and questionable safety of recombinant activated factor VII in intractable bleeding following cardiac surgery
    Tong, M. Z.
    Chin-Yee, I.
    Eckert, K.
    Kiaii, B.
    Quantz, M.
    Novick, R. J.
    CANADIAN JOURNAL OF CARDIOLOGY, 2007, 23 : 291C - 291C